{"id":"W2087779901","doi":"10.1007/s10637-014-0091-8","title":"A randomized phase II efficacy and safety study of vandetanib (ZD6474) in combination with bicalutamide versus bicalutamide alone in patients with chemotherapy naïve castration-resistant prostate cancer","year":2014,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Juravinski Cancer Centre; London Health Sciences Centre; BC Cancer Agency","funders":"","keywords":"Bicalutamide; Medicine; Vandetanib; Prostate cancer; Tolerability; Internal medicine; Urology; Oncology; Adverse effect; Pharmacology; Cancer; Tyrosine kinase; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002288957,0.002049749,0.00434904,0.0007631377,0.0007013287,0.001569034,0.001571348,0.001835004,0.007217194],"category_scores_gemma":[0.002456757,0.001475945,0.001978841,0.0008757297,0.002398723,0.001803433,0.0006252108,0.004905117,0.001240407],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001654141,"about_ca_system_score_gemma":0.001995961,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001953933,"about_ca_topic_score_gemma":0.004088109,"domain_scores_codex":[0.9987552,0.0007115036,0.00006156461,0.0001956348,0.00009271721,0.0001833759],"domain_scores_gemma":[0.9982204,0.0004421054,0.0003764796,0.000196215,0.00009963883,0.0006651562],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.973944,0.01199492,0.0007388745,0.0001478865,0.0006646342,0.0000317941,0.00003900666,0.000351082,0.002946363,0.00008891248,0.0005567762,0.0084957],"study_design_scores_gemma":[0.9234344,0.07387622,0.001310804,0.000006063967,0.0002971765,0.00002606693,0.00001648665,0.0002515686,0.0003010588,0.00008949335,0.0003777744,0.00001287508],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9898733,0.002036072,0.0007695987,0.0006919733,0.0005218748,0.003121837,0.001130125,0.0001185387,0.001736694],"genre_scores_gemma":[0.9876623,0.001759585,0.001806866,0.0009922925,0.0005959464,0.002787174,0.001483334,0.00005291068,0.002859468],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007217194,"threshold_uncertainty_score":0.02414393,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01768645514526797,"score_gpt":0.3041144943748178,"score_spread":0.2864280392295498,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}